Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Doxorubicin | gCSI | pan-cancer | AAC | -0.17 | 0.001 |
mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.18 | 0.001 |
mRNA | Irinotecan | gCSI | pan-cancer | AAC | -0.16 | 0.002 |
mRNA | Topotecan | CTRPv2 | pan-cancer | AAC | -0.084 | 0.008 |
mRNA | BYL-719 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.009 |
mRNA | CHIR-99021 | CTRPv2 | pan-cancer | AAC | -0.086 | 0.01 |
mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |
mRNA | cimetidine | CTRPv2 | pan-cancer | AAC | -0.17 | 0.01 |
mRNA | AZD7762 | CTRPv2 | pan-cancer | AAC | -0.081 | 0.01 |
mRNA | SB-525334 | CTRPv2 | pan-cancer | AAC | 0.091 | 0.01 |